Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer Clinic.

ABSTRACT: To compare liver cancer resectability rates before and during the COVID-19 pandemic.

Background

Liver cancers usually present with nonspecific symptoms or are diagnosed through screening programs for at-risk patients, and early detection can improve patient outcomes. In 2020, the COVID-19 pandemic upended medical care across all specialties, but whether the pandemic was associated with delays in liver cancer diagnosis is not known.

Methods

We performed a retrospective review of all patients evaluated at the Johns Hopkins Multidisciplinary Liver Cancer Clinic from January 2019 to June 2021 with a new diagnosis of suspected or confirmed hepatocellular carcinoma (HCC) or biliary tract cancer (BTC).

Results

There were 456 liver cancer patients (258 HCC and 198 BTC). From J

SUBMITTER: Li D 

PROVIDER: S-EPMC9782462 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature